arrow
M

Michele Prisciandaro

medical oncology department
H指数:24
被引数:2,251

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real world outcomes of perioperative FLOT in an Italian cohort of resectable gastric cancer: long term follow-up of prospective observational Real-FLOT study

可切除胃癌意大利队列中围手术期FLOT的长期随访真实世界结果:前瞻性观察性Real-FLOT研究

2026-09-170
OAAI
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis☆

针对左侧、非MSI-H、RAS/BRAF野生型转移性结直肠癌患者,基于抗EGFR的维持治疗与停药再给药的比较:个体患者数据合并分析☆

2026-06-100
OAAI
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials

原发肿瘤侧别及负超选择对RAS野生型转移性结直肠癌患者抗EGFR为基础维持疗法的影响:两项随机临床试验的个体患者数据合并分析

2025-08-280
OAAI
Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma

II期PANDORA试验的设计与原理:晚期默克尔细胞癌的一线化疗免疫疗法

2025-06-120
OA
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

曲美木单抗和度伐利尤单抗作为微卫星不稳定性高、可切除的胃或胃食管结合部腺癌患者的新辅助治疗或非手术治疗策略:GONO开展的INFINITY研究

2025-03-018
PRE
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trial
2024-09-010
PRE
Transcriptional features of stage IIT4N0/III colon cancer associated with residual disease and ctDNA status after surgery in the PEGASUS trial

PEGASUS试验中,与术后残留病灶及ctDNA状态相关的II期T4N0/III期结肠癌的转录特征

2024-09-010
PRE
Multicentre, multi-cohort, single-arm phase II trial of tremelimumab and durvalumab as neoadjuvant or definitive treatment of patients (pts) with microsatellite instabilityhigh (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC): The INFINITY study
2024-06-010
PRE
Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials

性别对局部晚期微卫星不稳定性高的胃或胃食管交界癌的预后和预测影响: 一项随机临床试验的个体患者数据汇总分析

2024-05-010
PRE
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
2023-09-016
OAAI
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors

BRCA2种系突变鉴定对PARP抑制剂有反应的胃癌

2023-05-026
OAAI
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the CARACAS study
2023-03-015
OAAI
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development
2023-02-0910
OA
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial

接受基于帕尼单抗的前期策略的患者的早期转移性结直肠癌: Valentino试验的总体和性别特异性结果

2022-06-239
OA
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers
2022-06-135
OA
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer
2022-04-018
PRE